Significant changes to the Pharmacy contract in England.
The agreement for year 3 of the Community Pharmacy Contractual framework in England between PSNC and NHSE&I has resulted in new services opportunities. The most significant changes at this stage are the expansion of the New Medicine Service (NMS) to additional therapeutic areas as below
Urinary incontinence or retention
Acute coronary syndromes
Long term risks of venous thromboembolism/embolism
Stroke / transient ischemic attack and
Coronary heart disease
These changes came into effect from the 1st of September as did a short term 6 month window to provide a ‘catch-up’ NMS to those patients who may have missed out on an NMS conversation but were prescribed a new medicine during the pandemic.
NMS completions will also be part of the Gateway criteria of this years PQS scheme which was also announced recently and will also be a key element in qualification for the transitional payment within the contract as this has been split between dispensing volume and service delivery
The second major change is the introduction of a Hypertension case finding service as an Advanced service from October 2021 or as soon as possible thereafter. This is following successful pilots of the scheme in selected areas. The service has two stages. The first is a blood pressure check following NICE guidelines and the second involves an ambulatory blood pressure monitoring (ABPM) where this is clinically indicated from the first stage. The service will require purchase of equipment and will be incentivised with payments of £1000 in the first year if the 5 ABPM interventions are completed in 2021/2022.
This message may contain confidential information. If you are not the intended recipient please inform the sender that you have received the message in error before deleting it.Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:to do so is strictly prohibited and may be unlawful..